- Home
- ARCT vs CRMD Comparison
ARCT vs CRMD Comparison
Compare ARCT & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARCT
- CRMD
- Stock Information
- Founded
- ARCT 2013
- CRMD 2006
- Country
- ARCT United States
- CRMD United States
- Employees
- ARCT N/A
- CRMD N/A
- Industry
- ARCT Biotechnology: Pharmaceutical Preparations
- CRMD Biotechnology: Pharmaceutical Preparations
- Sector
- ARCT Health Care
- CRMD Health Care
- Exchange
- ARCT Nasdaq
- CRMD Nasdaq
- Market Cap
- ARCT 298.3M
- CRMD 877.5M
- IPO Year
- ARCT N/A
- CRMD 2010
- Fundamental
- Price
- ARCT $13.78
- CRMD $11.28
- Analyst Decision
- ARCT Strong Buy
- CRMD Strong Buy
- Analyst Count
- ARCT 8
- CRMD 7
- Target Price
- ARCT $52.83
- CRMD $17.33
- AVG Volume (30 Days)
- ARCT 484.0K
- CRMD 2.3M
- Earning Date
- ARCT 08-04-2025
- CRMD 08-13-2025
- Dividend Yield
- ARCT N/A
- CRMD N/A
- EPS Growth
- ARCT N/A
- CRMD N/A
- EPS
- ARCT N/A
- CRMD 0.28
- Revenue
- ARCT $143,680,000.00
- CRMD $82,553,827.00
- Revenue This Year
- ARCT N/A
- CRMD $238.38
- Revenue Next Year
- ARCT $34.79
- CRMD $53.52
- P/E Ratio
- ARCT N/A
- CRMD $40.42
- Revenue Growth
- ARCT 15.38
- CRMD N/A
- 52 Week Low
- ARCT $8.04
- CRMD $3.61
- 52 Week High
- ARCT $25.88
- CRMD $17.43
- Technical
- Relative Strength Index (RSI)
- ARCT 54.34
- CRMD 39.54
- Support Level
- ARCT $13.10
- CRMD $11.13
- Resistance Level
- ARCT $15.20
- CRMD $11.86
- Average True Range (ATR)
- ARCT 1.02
- CRMD 0.65
- MACD
- ARCT 0.07
- CRMD -0.34
- Stochastic Oscillator
- ARCT 55.21
- CRMD 3.81
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in one business segment, which includes all activities related to the discovery, development and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU, and LUNAR-COV19.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.